Release Date: 21/09/15 10:58 Summary: Notice of Sep 2015 Quarter Results Release & Teleconference Price Sensitive: No Download Document 14.27KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%